Tetragenetics
Ithaca
About Tetragenetics
Tetragenetics is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Their technology is particularly well suited to the production of eucaryotic membrane and secretory proteins that are difficult to express in conventional systems. Such proteins include vaccine antigens, monoclonal antibodies, and a variety of therapeutic proteins for the treatment and prevention of human and animal disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Funding stage: M&A
- Last round: Debt Financing (Sep 2020)
- Website: tetragenetics.com
- Phone: 6174013754
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tetragenetics-24321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.